FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Baxter Healthcare Brevibloc Premixed Injection Recall

Brevibloc Premixed Injection, Esmolol Hydrochloride in Sodium Chloride, 2,500 mg/250 mL…

Baxter Healthcare Corp. · Deerfield, IL

Risk level
Class II
Reported by FDA
Jul 9, 2014
Recall ID
D-1413-2014
Check your lot numberHow we source this data

Summary

Baxter Healthcare recalled Brevibloc Premixed Injection starting Jun 16, 2014. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-1413-2014 on Jul 9, 2014. Reason: Presence of Particulate Matter: Complaints received of discolored solution identified as subvisible particles of iron oxide that are agglomerating. Status: Terminated.

Why it was recalled

Presence of Particulate Matter: Complaints received of discolored solution identified as subvisible particles of iron oxide that are agglomerating.

Product description

Brevibloc Premixed Injection, Esmolol Hydrochloride in Sodium Chloride, 2,500 mg/250 mL (10 mg/mL), 250 mL Single Use IntraVia container, packaged in 10 x 250 mL Single Use IntraVia containers per carton, Rx only, Baxter Healthcare Corporation, Deerfield, IL 60015 USA, Product Code 2J1415, NDC 10019-055-61.

Lot numbers, UPCs & expiration codes

Lot #: C926923, Exp 01/16

Where it was sold

Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1413-2014
Classification
Class II
Status
Terminated
Recall initiated
Jun 16, 2014
FDA report date
Jul 9, 2014
Quantity
20,810 containers
Recall type
Voluntary: Firm initiated
Recalling firm
Baxter Healthcare Corp.

Original FDA data

Every field from FDA enforcement report D-1413-2014, exactly as published.

Show all FDA fields
City
Deerfield
State
IL
Status
Terminated
Country
United States
Event ID
68577
Address
1 Baxter Pkwy
Code information
Lot #: C926923, Exp 01/16
Postal code
60015-4625
Report date
Jul 9, 2014
Product type
Drugs
Recall number
D-1413-2014
Classification
Class II
Recalling firm
Baxter Healthcare Corp.
Product quantity
20,810 containers
Termination date
Apr 10, 2017
Reason for recall
Presence of Particulate Matter: Complaints received of discolored solution identified as subvisible particles of iron oxide that are agglomerating.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Brevibloc Premixed Injection, Esmolol Hydrochloride in Sodium Chloride, 2,500 mg/250 mL (10 mg/mL), 250 mL Single Use IntraVia container, packaged in 10 x 250 mL Single Use IntraVia containers per carton, Rx only, Baxter Healthcare Corporation, Deerfield, IL 60015 USA, Product Code 2J1415, NDC 10019-055-61.
Distribution pattern
Nationwide
Recall initiation date
Jun 16, 2014
Initial firm notification
Letter
Center classification date
Jul 1, 2014

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1413-2014, published Jul 9, 2014. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls